Asthma in Patients With Japanese Cedar Pollinosis

被引:0
|
作者
Tanaka, Akihiko [1 ]
Minoguchi, Kenji [2 ]
Pawankar, Ruby [3 ]
Adachi, Mitsuru [1 ]
机构
[1] Showa Univ, Div Allergy & Resp Med, Dept Internal Med, Tokyo, Japan
[2] Sumiregaoka Clin, Yokohama, Kanagawa, Japan
[3] Nippon Med Sch, Tokyo, Japan
来源
WORLD ALLERGY ORGANIZATION JOURNAL | 2012年 / 5卷
关键词
Japanese cedar pollinosis; asthma; allergic rhinitis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea, nasal obstruction, nasal itching, and itching of the eyes. Previous reports indicate that the prevalence of Japanese cedar pollinosis among Japanese was 26.5%. According to a more recent questionnaire-based survey, the prevalence of Japanese cedar pollinosis in patients with adult asthma might be up to 30% to 50%, suggesting higher rates than that previously reported. Moreover, 30% to 60% of adult asthmatic patients with concomitant pollinosis have exacer-bations of their asthma symptoms during the Japanese cedar pollen season. These findings suggest that concomitant Japanese cedar pollinosis may be an aggravating factor in patients with asthma. As with other pollens, such as grass and birch, Japanese cedar pollen was shown to be a trigger factor for worsening asthma. In clinical practice, a number of Japanese patients with asthma are mono-sensitized to Japanese cedar pollen but not to other antigens. Further studies are needed to elucidate the mechanisms of Japanese cedar pollen in inducing and in exacerbating asthma. The presence of concomitant AR is often associated with the difficulty in asthma control. However, there has been a controversy whether treating concomitant AR by intranasal corticosteroid would produce better asthma-related outcomes in patients with asthma and AR. The effect of treating concomitant cedar pollinosis by intranasal corticosteroids on asthma control in patients with asthma and cedar pollinosis also remains unknown. Certain systemic treatments, such as leukotriene receptor antagonist and anti-IgE monoclonal antibody, are supposed to reduce the symptoms of both asthma and AR in patients with asthma and concomitant AR. In conclusion, Japanese cedar pollinosis is often associated with exacerbations of asthma. Further investigations are expected to elucidate the precise impact and mechanisms of Japanese cedar pollinosis in asthma.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
    Kong, Qingliang
    Kitaoka, Momoko
    Wakabayashi, Rie
    Tahara, Yoshiro
    Kamiya, Noriho
    Goto, Masahiro
    PHARMACEUTICS, 2020, 12 (03)
  • [32] Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
    Otsuka, Kuninori
    Otsuka, Hirokuni
    Matsune, Shoji
    Okubo, Kimihiro
    IMMUNITY INFLAMMATION AND DISEASE, 2020, 8 (03) : 333 - 341
  • [33] Analysis of factors associated with cedar pollen sensitization and development of pollinosis in a young Japanese adult population
    Nakamura, Satoshi
    Tsunoda, Sachiko
    Sakaida, Hiroshi
    Masuda, Sawako
    Said, Ahamad Shah
    Takeuchi, Kazuhiko
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (01) : 39 - 45
  • [34] Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis
    Yonekura, Syuji
    Okamoto, Yoshitaka
    Okawa, Toru
    Hisamitsu, Minako
    Chazono, Hideaki
    Kobayashi, Kouichi
    Sakurai, Daiju
    Horiguchi, Shigetoshi
    Hanazawa, Toyoyuki
    ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (04) : 397 - 405
  • [35] The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients
    Mueller, M.
    Igarashi, A.
    Hashiguchi, K.
    Kappel, M.
    Paolini, F.
    Yoshisue, H.
    Funakubo, M.
    Sharma, H.
    Okano, M.
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 220 - 229
  • [36] Prevalence and risk factors of allergic rhinitis and cedar pollinosis among Japanese men
    Sakurai, Y
    Nakamura, K
    Teruya, K
    Shimada, N
    Umeda, T
    Tanaka, H
    Yoshizawa, N
    PREVENTIVE MEDICINE, 1998, 27 (04) : 617 - 622
  • [37] Regulatory T and B cells in peripheral blood of subcutaneous immunotherapy-treated Japanese cedar pollinosis patients
    Matsuda, Masaya
    Terada, Tetsuya
    Tsujimoto, Nau
    Morie, Yuki
    Ishida, Tomoki
    Takahashi, Hiromu
    Hamaguchi, Junpei
    Tabuchi, Yuki
    Doi, Kana
    Noro, Keiki
    Kikuoka, Yusuke
    Omura, Shuji
    Yoshida, Takuya
    Ayani, Yusuke
    Suzuki, Manabu
    Ichihara, Takahiro
    Inaka, Yuko
    Inui, Takaki
    Kawata, Ryo
    Nabe, Takeshi
    IMMUNOTHERAPY, 2019, 11 (06) : 473 - 482
  • [38] Current cat ownership may be associated with the lower prevalence of atopic dermatitis, allergic rhinitis, and Japanese cedar pollinosis in schoolchildren in Himeji, Japan
    Kurosaka, F
    Nakatani, Y
    Terada, T
    Tanaka, A
    Ikeuchi, H
    Hayakawa, A
    Konohana, A
    Oota, K
    Nishio, H
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (01) : 22 - 28
  • [39] Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber
    Hashiguchi, Kazuhiro
    Kanzaki, Sho
    Wakabayashi, Ken-ichiro
    Tanaka, Nobuaki
    Kawashima, Kayoko
    Suematsu, Kiyochika
    Tokunaga, Shoji
    Ogawa, Kaoru
    Okubo, Kimihiro
    JOURNAL OF DRUG ASSESSMENT, 2013, 2 (01) : 94 - 105
  • [40] MAJOR BASIC-PROTEIN, EOSINOPHIL CATIONIC PROTEIN, AND ARYLSULFATASE IN NASAL SECRETIONS OF PATIENTS WITH JAPANESE CEDAR POLLINOSIS
    NISHIOKA, K
    OGAWA, T
    SAITO, C
    NISHIOKA, S
    NAKAGAWA, F
    OHOMICHI, T
    MASUDA, Y
    ACTA MEDICA OKAYAMA, 1995, 49 (01) : 29 - 33